English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
DNX Biopharmaceuticals Announces Collaboration with Lung Cancer Initiative at Johnson & Johnson
Feb 19, 2020 00:00 HKT
AIM ImmunoTech Issues Stockholder Update on the Potential Role of Ampligen for Use Against the Wuhan Coronavirus Epidemic
Feb 18, 2020 19:30 HKT
Blue Orca's Short Selling Plan Failed Because the Quality China Medical System (867.HK) Can Withstand Severe Tests
Feb 14, 2020 18:00 HKT
China Medical System (867.HK) Armed against Short Selling! The Biggest CSO Took Control of Full Industrial Chain
Feb 14, 2020 17:25 HKT
Hua Medicine appoints Dr. Fuxing Tang, a former U.S. FDA Officer, as Chief Technology Officer
Feb 14, 2020 15:21 HKT
AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen(R) for Use Against the SARS-like Wuhan 2019 Novel Coronavirus
Feb 11, 2020 19:30 HKT
Aptorum Group Announces Further Positive Data for its ALS-4 Small Molecule Anti-virulence (Non-bactericidal) Drug Candidate for Treatment of Infections caused by Staphylococcus Aureus
Feb 11, 2020 11:14 HKT
Bayer, Meiogenix Collaborate to Accelerate Agricultural Innovation Through the Development of Unique Technologies
Feb 10, 2020 15:00 HKT
Malaysians Rush for Anti-Virus Sanitiser, NatShield(TM), after Pharmacies Restock on Concerns of Spread of Deadly Disease
Feb 06, 2020 16:00 HKT
Livingstone Health Unveils New Corporate Identity; Adds Cardiology and Family Medicine Capabilities
Feb 06, 2020 13:00 HKT
Swallowing difficulty may be caused by spinal disease, says study by Hong Kong Chiropractors
Feb 03, 2020 17:00 HKT
Orders for NatShield Sanitizer Spike after Outbreak of Coronavirus
Jan 30, 2020 16:00 HKT
Asia-Pacific has Record Year for Clinical Trials says Novotech CRO
Jan 21, 2020 10:40 HKT
SinoMab Granted the "Most Popular Newly Listed Company" Award
Jan 10, 2020 12:18 HKT
Tauriga Sciences, Inc. Approved by Alibaba Group to Operate Global Seller Account
Jan 07, 2020 08:00 HKT
TOT BIOPHARM Biological Drug R&D Project Makes List of National Major Scientific and Technological Special Projects for "Significant New Drug Development"
Jan 02, 2020 18:11 HKT
Viva Biotech Was Included as a Constituent Stock of the Hang Seng Hong Kong-Listed Biotech Index
Dec 19, 2019 08:40 HKT
TOT BIOPHARM Included in the "Suzhou Industrial Park - 2019 Awarded Listed Enterprises"
Dec 16, 2019 08:30 HKT
Holista Files Patent for Water-Soluble Technology Targeting Cannabidiol (CBD) and Other High-Value, Fat-Soluble Nutraceuticals
Dec 12, 2019 12:00 HKT
Sino Biopharmaceutical Announces 2019 Third Quarterly Results
Nov 26, 2019 19:50 HKT
<< Previous  Next >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: